Business
Press Release Sep 09 2023
Strides Pharma Science Limited has informed the Exchange regarding a press release dated September 09, 2023, titled "Strides receives USFDA approval for Sevelamer Carbonate for Oral Suspension".
About this update from Strides Pharma Science Ltd
[{"type":"text","content":" Strides Pharma Science Limited has informed the Exchange regarding a press release dated September 09, 2023, titled \"Strides receives USFDA approval for Sevelamer Carbonate for Oral Suspension\". View Attachment","length":342,"tagName":"div"}]